Dow Advances, S&P Ekes Out Gain as Vaccine Timeline Comes Into Focus

[unable to retrieve full-text content]The S&P 500 posted a nominal gain on Friday as further clarity regarding the timeline for the development of a coronavirus vaccine and much better-than-expected retail sales data brought buyers back …